|
1 Indications And Usage Segluromet™ Is Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus Who Are Not Adequately Controlled On A Regimen Containing Ertugliflozin Or Metformin, Or In Patients Who Are Already Treated With Both Ertugliflozin And Metformin. Segluromet Is A Combination Of Ertugliflozin, A Sodium Glucose Co-Transporter 2 (Sglt2) Inhibitor, And Metformin, A Biguanide, Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus Who Are Not Adequately Controlled On A Regimen Containing Ertugliflozin Or Metformin, Or In Patients Who Are Already Treated With Both Ertugliflozin And Metformin. ( 1 ) Limitations Of Use: Not For The Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis. ( 1 ) Limitations Of Use Segluromet Is Not Recommended In Patients With Type 1 Diabetes Mellitus Or For The Treatment Of Diabetic Ketoacidosis.
|